Targeting treatment-resistant breast cancer stem cells with FKBPL and its peptide derivative, AD-01, via the CD44 pathway. od McClements, L, Yakkundi, A, Papaspyropoulos, A, Harrison, H, Ablett, M, Jithesh, P, McKeen, H, Bennett, R, Donley, C, Kissenpfennig, A, McIntosh, S, McCarthy, H, O'Neill, E, Clarke, R, Robson, T